Palvella Therapeutics (PVLA) Net Margin (2014 - 2024)
Palvella Therapeutics (PVLA) reported Net Margin of -5150.94% for Q1 2024, down 4494.23 percentage points from -656.72% a year earlier and down 8129.47 percentage points from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Net Margin (2014 - 2024) Analysis & Trends
For FY2023, Palvella Therapeutics posted Net Margin of 41.85%, up 170.41 percentage points from FY2022.
- Net Margin has a five-year change of +133.78 percentage points (FY2018 to FY2023).
- By year, Net Margin came in at -128.56% in FY2022 (+17.02 pp), -145.58% in FY2021 (-18.61 pp), -126.97% in FY2020 (-65.82 pp) and -61.15% in FY2019 (+30.79 pp).
- The Q1 2024 figure ranks as the lowest quarterly Net Margin in data going back to Q1 2015.
- Year over year, Net Margin gained in five of the last eight quarters, with an average year-over-year change of -146.23 percentage points.
- The high point for year-over-year Net Margin in five years was Q4 2023 (a gain of 3117.51 percentage points); the low point was Q1 2024 (a drop of 4494.23 percentage points).
- Per Business Quant data, the three quarters before Q1 2024 came in at 2978.52% (Q4 2023), -55.33% (Q3 2023) and 19.91% (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Palvella Therapeutics | 2.01 Bn | 1.76 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -5,150.94% |
| Dec 31, 2023 | 2,978.52% |
| Sep 30, 2023 | -55.33% |
| Jun 30, 2023 | 19.91% |
| Mar 31, 2023 | -656.72% |
| Dec 31, 2022 | -138.98% |
| Sep 30, 2022 | -181.30% |
| Jun 30, 2022 | -279.56% |
| Mar 31, 2022 | -45.63% |
| Dec 31, 2021 | -112.90% |
| Sep 30, 2021 | -407.59% |
| Jun 30, 2021 | -471.84% |
| Dec 31, 2020 | -767.18% |
| Sep 30, 2020 | -486.56% |
| Jun 30, 2020 | -44.46% |
| Mar 31, 2020 | -27.15% |
| Dec 31, 2019 | -4.64% |
| Sep 30, 2019 | -17.13% |
| Jun 30, 2019 | -220.52% |
| Mar 31, 2019 | -121.10% |
API Access
Palvella Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();